[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oxford Biodynamics Plc (OBD.LN)

Oxford Biodynamics Plc (OBD.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oxford Biodynamics Plc John Smith Drive 3140 Rowan Place Oxford OX4 2WB GBR

https://www.oxfordbiodynamics.com P: 186-551-8910

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.

Key Statistics

Overview:

Market Capitalization, $K 8,153
Shares Outstanding, K 4,290,911
% of Insider Shareholders 15.62%
% of Institutional Shareholders 25.44%

Financials:

Annual Sales, $ 1,095 K
Annual Net Income, $ -11,153 K

Growth:

1-Year Return -48.57%
3-Year Return -98.50%
5-Year Return -99.67%
5-Year Revenue Growth 19.15%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.01
Dividend Payout Ratio 0.00%

OBD.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -407.49%
Return-on-Assets % -110.46%
Profit Margin % -1,018.54%
Debt/Equity 3.43
Price/Sales 2.41
Price/Book 7.31
Book Value/Share 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.